The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of prostate cancer.
The following sections include:- Associated ICD-9-CM codes used for the classification of prostate cancer
- Drugs that have been FDA approved in the treatment of prostate cancer
- Drugs that are Compendia-listed for off-label use for prostate cancer based on clinical studies that suggest beneficial use in some cases. Please note: If a check mark appears in the FDA column, it will NOT appear in the Compendia off-label use column
- Corresponding HCPCS/CPT® codes and code descriptions